```html

Juvenile Nasopharyngeal Angiofibroma (JNA) – A Complete Patient Guide

Overview

Juvenile nasopharyngeal angiofibroma (JNA) is a rare, benign (non‑cancerous) tumor that arises in the nasopharynx – the upper part of the throat behind the nose. Although it does not spread (metastasize) to distant organs, JNA is highly vascular and locally aggressive, meaning it can erode nearby bone and extend into the sinuses, orbit, or even the skull base.

• Typical age: Adolescents, usually between 12 and 19 years.
• Gender: >90 % occur in males; the disease is considered androgen‑dependent.
• Prevalence: Approximately 0.05–0.1 per 100,000 people worldwide, making it one of the most common benign nasopharyngeal tumors in teenagers but still a rare condition overall.<sup>[1]</sup>

Because JNA grows slowly yet can cause significant bleeding, early recognition and treatment are essential. The condition is not related to malignancy, but its location and vascularity make it a surgical challenge.

Symptoms

Symptoms arise from the tumor’s size, location, and vascular nature. Not every patient experiences all of them, but the following list covers the most commonly reported complaints:

Nasal and Sinus‑Related Symptoms

• Unilateral nasal obstruction: A feeling of blockage on one side of the nose, often progressive.
• Recurrent epistaxis (nosebleeds): Bright red, sometimes profuse bleeding that may require gauze packing. This is the hallmark symptom in >70 % of cases.<sup>[2]</sup>
• Post‑nasal drip or chronic nasal discharge: Usually clear or serosanguinous.

Facial and Oral Symptoms

• Facial fullness or swelling: Particularly over the cheek or behind the eye.
• Dental pain or malocclusion: When the tumor extends into the maxillary sinus.
• Difficulty with chewing or speaking: Rare, but can occur with large lesions.

Ear‑Related Symptoms

• Conductive hearing loss: Due to blockage of the eustachian tube.
• Ear fullness or occasional otorrhea (ear discharge).

Neurologic Symptoms (advanced disease)

• Headache or facial pain: From bone erosion or sinus pressure.
• Visual disturbances: Double vision, reduced vision, or proptosis when the tumor reaches the orbit.
• Nasal speech or hypernasality: When the soft palate is involved.

Causes and Risk Factors

The exact cause of JNA remains unclear, but several theories and risk factors have been identified:

Hormonal Influence

• The tumor expresses androgen receptors and grows during puberty, suggesting a link to male sex hormones.
• Rare cases in females are typically associated with high androgen states (e.g., polycystic ovary syndrome) or androgen therapy.

Genetic Factors

• Familial clustering is extremely uncommon, but sporadic chromosomal abnormalities (e.g., translocation t(4;8)(q21;q13)) have been reported.<sup>[3]</sup>

Environmental & Lifestyle

• No strong environmental triggers have been proven. Smoking and exposure to airborne irritants do not appear to increase risk.

Risk Summary

• Male adolescents (12‑19 y) – highest risk.
• Family history of JNA – very low but possible.
• Hormonal abnormalities – very uncommon.

Diagnosis

Because JNA is highly vascular, careful evaluation is needed to avoid dangerous bleeding during examination.

Clinical Evaluation

• Detailed history focusing on unilateral nasal obstruction and epistaxis.
• Physical examination with a nasal endoscope (rigid or flexible) performed by an ENT specialist. Direct visualization often reveals a reddish‑purple mass behind the middle turbinate.

Imaging Studies

1. CT (Computed Tomography) Scan: Shows a soft‑tissue mass with bone remodeling or erosion, especially of the sphenopalatine foramen and pterygopalatine fossa.
2. MRI (Magnetic Resonance Imaging): Provides superior soft‑tissue contrast; typical “salt‑and‑pepper” appearance due to flow voids from high vascularity.
3. Angiography (Digital Subtraction Angiography – DSA): Gold standard for defining feeding vessels (usually branches of the internal maxillary artery). Allows pre‑operative embolization to reduce intra‑operative bleeding.

Biopsy Considerations

Biopsy is generally contraindicated unless imaging is equivocal because the tumor can bleed profusely. Diagnosis is usually made on imaging plus clinical presentation.

Staging

Several staging systems exist (e.g., Radkowski, Fisch). Staging guides treatment choice and predicts prognosis. Radiologic staging assesses extent into the nasal cavity, sinuses, orbit, and skull base.

Treatment Options

Management must balance complete tumor removal with preservation of surrounding structures and control of bleeding.

1. Surgical Resection (Mainstay)

• Endoscopic Endonasal Approach: Preferred for Stage I‑II disease. Uses video‑assisted endoscopy through the nose, avoiding external incisions.
• Open Approaches (e.g., Caldwell‑Luc, maxillary swing, lateral rhinotomy): Reserved for large, posterior or skull‑base‑extending tumors (Stage III‑IV).
• Goal: complete excision while minimizing blood loss.

2. Pre‑operative Embolization

Performed 24‑48 hours before surgery via interventional radiology. Embolization of feeding arteries reduces intra‑operative blood loss by up to 70 % and improves visualization.<sup>[4]</sup>

3. Radiation Therapy

• Indicated for unresectable tumors, residual disease after surgery, or recurrence.
• Modern techniques (IMRT, proton therapy) limit exposure to surrounding tissue.
• Typical dose: 45–50 Gy in fractions.

4. Hormonal or Medical Therapy

• Historical use of anti‑androgens (e.g., flutamide) showed limited benefit and significant side effects; not routinely recommended.
• Newer agents targeting angiogenesis (bevacizumab) are under investigation but lack robust evidence.

5. Observation

Small, asymptomatic lesions discovered incidentally may be monitored with serial imaging, especially in very young patients where surgery could affect growth. However, most clinicians favor early intervention because of the bleeding risk.

6. Post‑operative Care & Lifestyle

• Nasogastric suction or humidified air to keep nasal passages moist.
• Avoid nose blowing or strenuous activity for 2‑3 weeks post‑op to prevent re‑bleeding.
• Regular follow‑up endoscopy and imaging (usually MRI at 6 months, then annually for 5 years).

Living with Juvenile Nasopharyngeal Angiofibroma

Even after successful treatment, patients may need ongoing strategies to maintain health and quality of life.

Daily Management Tips

• Nasal Hygiene: Saline nasal sprays or irrigations (e.g., Neti pot) keep the nasal mucosa moist and reduce crust formation.
• Bleeding Precautions: Keep a cold compress and a small pack of gauze handy. Avoid aspirin, ibuprofen, or other NSAIDs unless directed by a physician, as they can impair clotting.
• Activity Modification: Refrain from contact sports, heavy lifting, or activities that raise intrathoracic pressure for at least 4‑6 weeks post‑surgery.
• Dental Care: Inform the dentist about the diagnosis; some maxillary procedures may be needed if sinus involvement persists.
• Emotional Support: Adolescents may feel anxious about facial appearance or future ENT procedures. Counseling or support groups (e.g., American Rhinologic Society patient forums) can be beneficial.

Follow‑up Schedule

1. First post‑op visit: 2 weeks (wound check, nasal packing removal).
2. Endoscopic exam at 3 months, then MRI at 6 months.
3. Annual ENT check‑ups with endoscopy for at least 5 years; after that, intervals may be extended if no recurrence.

Prevention

Because JNA’s etiology is largely hormonal and possibly genetic, there are no proven preventive measures. However, general health practices can reduce complications:

• Promptly seek care for persistent unilateral nosebleeds or nasal blockage.
• Avoid self‑packing or aggressive nasal cleaning that could traumatize a hidden tumor.
• Maintain good overall health; while not preventive, a strong immune system helps with recovery after surgery.

Complications

If left untreated or incompletely removed, JNA can lead to serious outcomes:

• Severe Hemorrhage: Massive epistaxis may require emergency blood transfusion.
• Bone Destruction: Erosion of the maxilla, palate, or skull base can cause facial deformity and functional deficits.
• Orbital Invasion: Leads to diplopia, vision loss, or proptosis.
• Intracranial Extension: Rare but can cause meningitis, seizures, or cranial nerve palsies.
• Recurrence: Occurs in 10‑30 % of cases, especially when resection is incomplete. Recurrence may be more aggressive and require repeat surgery or radiation.
• Post‑Surgical Scarring: May lead to chronic nasal obstruction or sinusitis.

When to Seek Emergency Care

---

Sources: [1] NCBI – Juvenile Nasopharyngeal Angiofibroma Review; [2] Mayo Clinic; [3] Genetic Findings in JNA; [4] Cleveland Clinic; CDC, NIH, WHO guidelines accessed June 2026.

```